Oncology & Cancer

New hope of a treatment for aggressive T-PLL leukaemia

Until now, there has been no adequate treatment available for the rare and highly aggressive malignant blood disease T-PLL leukaemia. By screening blood samples from patients with haematological diseases, a team of doctors ...

Oncology & Cancer

CLL evolution under the microscope

How do initially benign forms of cancer evolve to become aggressive? In a quest to answer this long-standing question, an EU project has studied the growth and clonal evolution of chronic lymphocytic leukaemia (CLL)—a blood ...

Diseases, Conditions, Syndromes

Methylprednisolone trial for Berger's disease stopped early

Methylprednisolone is a prescription drug used to treat conditions involving inflammation, like asthma, arthritis, gout, tendinitis, transplant rejection, allergic reactions, and the skin conditions eczema and psoriasis.

Oncology & Cancer

New approach to leukaemia can help improve successful treatment

New University of Liverpool research, presented at an international conference, confirms that a novel approach to the treatment of chronic myeloid leukaemia (CML) can safely increase treatment success and reduce negative ...

Oncology & Cancer

New insights into T-cell acute lymphoblastic leukaemia development

A research team from the National University of Singapore (NUS) led by Assistant Professor Takaomi Sanda, Principal Investigator from the Cancer Science Institute of Singapore and Department of Medicine at NUS Yong Loo Lin ...

page 8 from 17